Advertisement

Topics

Search Results for "BIAL Pharmaceuticals"

16:13 EST 11th February 2016 | BioPortfolio

Matching Channels

None

Matching News

Bial’s Zebinix meets Phase III endpoints in new epilepsy study

Bial Portela, Portugal’s largest drugmaker, has released positive results for a pivotal Phase III non-inferiority…

Bial Trial Tragedy: No Safety Clue From Similar Products

Though officially unconfirmed, it is presumed that the fatty acid amide hydrolase inhibitor at the center of the Bial clinical trial disaster is BIA 10-2474, which was in Phase I development for the t...

Ph I trial of Bial pain drug sees one volunteer brain-dead

In a serious safety failure during a Phase I trial of a pain drug under development by Bial Portela,…

Ph I trial of Bial pain drug sees one volunteer die

In a serious safety failure during a Phase I trial of a pain drug under development by Bial Portela,…

Bial Drug Sparks French Clinical Trial Tragedy

Portugal-based Bial-Portela & Ca. S.A. is the manufacturer of the experimental medicine that sent six male volunteers in a trial of the drug to hospital in France, one of whom is on life support and i...

Helsinn licenses BIAL for anamorelin distribution

Helsinn Group has entered into an exclusive distribution and license agreement with BIAL for the exclusive…

Bial is maker of trial drug that hospitalised six volunteers - French minister

PARIS, Jan 15 (Reuters) - Portugal-based Bial lab is the manufacturer of the experimental medicine that sent six male volunteers in a trial of the drug to hospital in France, French Health Minister Ma...

Janssen Voluntarily Suspends FAAH Inhibitor Phase 2 Trials In Wake Of Bial Tragedy

While their drug has shown no adverse reactions in Phase 1 studies or ongoing Phase 2 trials to date, Janssen discontinues FAAH inhibitor dosing in two trials until more is known about the Bial drug t...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement